So here's a fun thing Robinhood is doing now. You know them as the app where you can buy a fractional share of Apple (AAPL) or Tesla (TSLA) with your coffee money. Now, through a new publicly traded fund, they're trying to let you do something similar with companies that aren't even on the stock market yet.
On Tuesday, Robinhood Markets, Inc. (HOOD) announced that its Robinhood Ventures Fund I (RVI) has made investments in two big-name private companies: the payments processing behemoth Stripe and the AI voice cloning startup ElevenLabs. The fund put about $14.6 million into Stripe and close to $20 million into ElevenLabs. That's over $34 million total going into what Robinhood calls "frontier companies" in fintech and artificial intelligence.
The stock liked the news, rising 1.46% to $76.41. It's riding a bit of a broader market updraft, but the move also highlights Robinhood's latest strategy.
Think of Robinhood Ventures Fund I as a special purpose vehicle that went public on the NYSE back on March 6, 2026. Its whole pitch is concentration and access. Instead of a giant, diversified ETF, it wants to build a focused portfolio of maybe 10-15 private companies it thinks are winners. And the key part? You don't need to be a certified rich person—an "accredited investor"—to buy shares of the fund. There's no investment minimum either. It's the Robinhood ethos, applied to the private markets.
"Our commitment is to provide retail investors access to these frontier companies, which are shaping the future of their respective industries," said Sarah Pinto, President of Robinhood Ventures Fund I. The fund's portfolio already includes names like Airwallex and Databricks alongside the new additions.
Okay, so the fund is doing its thing. What does this mean for Robinhood's own stock, HOOD? Let's break it down.
Technical Analysis
The charts are telling a bit of a mixed story. The stock is currently trading 0.35% below its 20-day simple moving average, which suggests some near-term softness. It's also sitting a hefty 29.7% below its 100-day average, indicating it's been in a longer-term downtrend from higher levels.
But zoom out, and the picture improves. Over the past year, shares are up a whopping 82.76%, and they're hanging out closer to their 52-week highs than their lows. That's a solid recovery from whatever was dragging it down before.
The Relative Strength Index (RSI) is at 42.13, which is basically neutral—not overbought, not oversold. Meanwhile, the MACD indicator is at -3.6501, with its signal line at -4.4995. Because the MACD is above the signal line, technicians call that a bullish crossover.
So you've got neutral short-term momentum (RSI) but a potential buy signal from the MACD. It's not a screaming "all-in" sign, but it hints there might be some upward gas in the tank.
- Key Resistance: $85.00
- Key Support: $70.50
Earnings & Analyst Outlook
The next big date for HOOD is the estimated earnings report on April 29, 2026. The expectations are for growth:
- EPS Estimate: 52 cents (Up from 37 cents YoY)
- Revenue Estimate: $1.26 billion (Up from $927.00 million YoY)
That growth comes at a price, though. The stock trades at a P/E of 36.7x, which is a premium valuation. The market is paying up for that expected growth.
Analysts, on the whole, are still fans. The consensus rating is a Buy, with an average price target way up at $136.59. That said, a couple of firms have recently dialed back their optimism a notch:
- Mizuho: Outperform (Lowers Target to $110.00) (Mar. 13)
- Cantor Fitzgerald: Overweight (Lowers Target to $100.00) (Feb. 17)
- Mizuho: Outperform (Lowers Target to $135.00) (Feb. 17)
